Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1988-08-15
1990-04-03
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424 11, A61K 3722
Patent
active
049139070
ABSTRACT:
The therapeutic compositions of this invention comprise one or more porphycene compounds incorporated within liposomes. The method of this invention for treating cancer comprises administering a therapeutically effective amount of a porphycene derivative to a patient, and exposing an affected body area of the patient to a therapeutically sufficient amount of light having a wavelength of from 600 to 950 nm.
REFERENCES:
patent: 4448765 (1984-05-01), Ash et al.
patent: 4452747 (1984-06-01), Gersonde et al.
patent: 4649151 (1987-03-01), Dougherty et al.
patent: 4656186 (1987-04-01), Bommer et al.
patent: 4693885 (1987-09-01), Bommer et al.
Anonymous, "Kodak to Finance Cancer Research", Chronicle Wire Service.
Anonymous, "Light Sources and Dosimetry", Yearly Review.
Anonymous, "Perspective: Cancer Drugs. Celltech Launches a Homing Missile".
Anonymous, "Photodynamic Therapy", press release, Quadra Logic Technologies (1987).
Anonymous, "QLT's Chinese Plans." Scrip 1316:15 (Jun. 10, 1988).
P. F. Aramendia et al, "The Photophysical Properties of Porphycenes: Potential Photodynamic Therapy Agents", Photochem. Photobiol. 44:555-559 (1986).
D. C. Blakey et al., "Effect of Chemical Deglycosylation of Ricin A Chain on the in vivo Fate and Cytotoxic Acitivity . . . ", Canc. Res. 47:947-952 (1987).
D. C. Blakely et al, "Antibody Toxin Conjugates", Progress in Allergy: Monoclonal Antibodies (in press).
G. Bylinsky, "Science Scores a Cancer Breakthrough", Fortune, p. 16, Nov. 25, 1985.
Dougherty and Kessel, eds., Porphyrin Photosensitisation, New York: Plenum Press (1983).
Dougherty et al, "Photoradiation Therapy of Human Tumors." The Science of Photomedicine, New York: Plenum Press (1982).
Guardiano et al, "Tetra-n-Propylporphycene as a Tumor Localizer: Pharmacokinetic and Phototherapeutic Studes in mice." (In Press).
D. Mew et al, "Photoimmunotherapy: Treatment of Animal Tumors With Tumor-Specific Monoclonal Antibody-Hematoporphyrin Conjugates", J. Immunol. 130:1473 (1983).
D. Mew et al, "Ability of Specific Monoclonal Antibodies and Conventional Antisera Conjugated to Hematoporphyrin . . . ", Canc. Res. 45:44380-4386 (1980).
H. Ofir et al, "The Photoexcited Triplet State of Porphycene, a Novel Porphin Isomer . . . ", J. Phys. Chem. 39:2686-2688 (1987).
C. Robbins-Roth, "Second International Conference on Monoclonal Antibody Immunoconjugates for Cancer" (1987).
I. Saito et al., "New Singlet Oxygen Source and Trapping Reagent for Perioxide Intermediates", Free Radical Res. 2:327-336 (1987).
P. E. Thorpe et al, "Comparison of Two Anti-Thy 1.1-Abrin A-Chain Immunotoxins Prepared With Different Cross-Linking Agents . . . ", J.N.C.I. 79:1101-1111 (1987).
P. E. Thorpe et al, "New Coupling Agents for the Synthesis of Immunotoxins Containing a Hindered Disulfide Bond . . . ", Cancer Res. 47:5924-5931 (1987).
E. S. Vitetta et al., "Immunotoxins: A New Approach to Cancer Therapy", Science 219:644-650 (1987).
E. S. Vitetta et al, "Redesigning Nature's Poisons to Create Anti-Tumor Reagents", Science 238:1098-1104 (1987).
Vogel et al, Angew Chem. 98:262/"Porphycene--a Novel Porphin Isomer", Agnew. Chem. Int. Ed. Engl. 25:257-259 (1986).
Vogel et al, Agnew. Chem. 99:909-917/"2,7,12,17-Tetrapropylporphycene . . . ", Agnew. Chem. Int. Ed. Engl. 26:928 (1987).
Vogel et al, Angew. Chem. 99:912 (In German).
B. Wehrle et al, "N-CPMAS-NMR-Untersuchungen des Problems der NH-Tautomerie in Kristallinem Porphin und Porphycen", Agnew. Chem 99:914 (1987).
R. J. Youle et al, "Anti-Thy 1.2 Monoclonal Antibody Linked to Ricin is a Potent Cell-Type-Specific Toxin", Proc. Nat. Acad. Sci. U.S.A. 77:5483-5486 (1980).
G. Jori et al, "Preferential Delivery of Liposome-Incorporated Porphyrins to Neoplastic Cells in Tumour-Bearing Rats.", J. Canc. Res. 48:307-309 (1983).
G. Jori, "Experiments on the Photodynamic Therapy of Tumours with Tetrapropylporphycene (TPP)", unpublished work.
Levanon et al, "Triplet-State Formation of Porphycenes: Intersystem Crossing Versus Sensitization Mechanisms", J. Phys. Chem. 92:2429-33 (1988).
A. U. Khan, "Activated Oxygen: Singlet Molecular Oxygen and Superoxide Anion", Photochem. Photobiol. 28:615-627 (1978).
Cross Alexander D.
Jori Giulio
Kocher Matthias
Vogel Emanuel
Cytopharm, Inc.
Page Thurman K.
Prater P. L.
Walker William B.
LandOfFree
Porphycene anti-cancer agents and treatment methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porphycene anti-cancer agents and treatment methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porphycene anti-cancer agents and treatment methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1356478